Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)
Trial details
- Registry ID
- NCT06999902
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)NCT06999902 | Praxis Precision Medicines | Phase 2, Phase 3 | Completed | 2026-05-14Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |